Jafron Biomedical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -19.55% vs -21.92% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -19.05% vs -24.85% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "471.90",
          "val2": "586.60",
          "chgp": "-19.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "217.00",
          "val2": "266.30",
          "chgp": "-18.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "12.40",
          "val2": "12.60",
          "chgp": "-1.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "9.30",
          "val2": "8.70",
          "chgp": "6.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "162.30",
          "val2": "200.50",
          "chgp": "-19.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "384.40%",
          "val2": "393.70%",
          "chgp": "-0.93%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -24.92% vs 39.19% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -34.70% vs 91.26% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,986.80",
          "val2": "2,646.20",
          "chgp": "-24.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "845.50",
          "val2": "1,140.00",
          "chgp": "-25.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "53.90",
          "val2": "64.20",
          "chgp": "-16.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-37.90",
          "val2": "-4.20",
          "chgp": "-802.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "531.70",
          "val2": "814.20",
          "chgp": "-34.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "357.00%",
          "val2": "376.30%",
          "chgp": "-1.93%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY

Jun'26

Jun'25

Change(%)

Net Sales

471.90

586.60

-19.55%

Operating Profit (PBDIT) excl Other Income

217.00

266.30

-18.51%

Interest

12.40

12.60

-1.59%

Exceptional Items

9.30

8.70

6.90%

Consolidate Net Profit

162.30

200.50

-19.05%

Operating Profit Margin (Excl OI)

384.40%

393.70%

-0.93%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2026 is -19.55% vs -21.92% in Jun 2025

Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is -19.05% vs -24.85% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,986.80

2,646.20

-24.92%

Operating Profit (PBDIT) excl Other Income

845.50

1,140.00

-25.83%

Interest

53.90

64.20

-16.04%

Exceptional Items

-37.90

-4.20

-802.38%

Consolidate Net Profit

531.70

814.20

-34.70%

Operating Profit Margin (Excl OI)

357.00%

376.30%

-1.93%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -24.92% vs 39.19% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -34.70% vs 91.26% in Dec 2024

All Annual Results